CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade TherapyShiney Rashmitha Chandraganti, Anushka Dongre, Sarthak Sahoo et al.|Cancer Research Communications|2026Cited by 3
Supplementary Figure S6 from CD4<sup>+</sup> T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade TherapyShiney Chandraganti, Anushka Dongre, Caitlyn Sams et al.|Unknown|2026Cited by 0
Supplementary Figure S5 from CD4<sup>+</sup> T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade TherapyShiney Chandraganti, Anushka Dongre, Caitlyn Sams et al.|Unknown|2026Cited by 0
Figure 2 from CD4<sup>+</sup> T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade TherapyShiney Chandraganti, Anushka Dongre, Caitlyn Sams et al.|Unknown|2026Cited by 0
Supplementary Figure S4 from CD4<sup>+</sup> T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade TherapyShiney Chandraganti, Anushka Dongre, Caitlyn Sams et al.|Unknown|2026Cited by 0